3,4-methylenedioxyamphetamine has been researched along with Pervasive Child Development Disorders in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shumaker, L | 1 |
| Cornell, C | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Love, autism style.
Topics: Child Development Disorders, Pervasive; Courtship; Disability Evaluation; Family Relations; Humans; | 2012 |
Transition years: from learning, living and loving to maintenance and mediocrity.
Topics: Adaptation, Psychological; Aging; Caregivers; Child Development Disorders, Pervasive; Empathy; Femal | 2012 |